- Home
- OM vs ANIX Comparison
OM vs ANIX Comparison
Compare OM & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OM | ANIX |
|---|---|---|
| Founded | 2003 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.9M | 104.0M |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | OM | ANIX |
|---|---|---|
| Price | $3.19 | $2.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $13.33 | $9.00 |
| AVG Volume (30 Days) | ★ 290.2K | 120.1K |
| Earning Date | 05-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.82 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $119,476,000.00 | $210,000.00 |
| Revenue This Year | $9.16 | N/A |
| Revenue Next Year | $11.19 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 5.09 | N/A |
| 52 Week Low | $0.53 | $2.33 |
| 52 Week High | $21.98 | $5.46 |
Technical Indicators
Market Signals| Indicator | OM | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 34.85 | 40.30 |
| Support Level | $3.12 | $2.69 |
| Resistance Level | $4.97 | $3.11 |
| Average True Range (ATR) | 0.23 | 0.14 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 14.17 | 22.93 |
Price Performance
Historical ComparisonAbout OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.